Kreaxi
  • Our DNA
  • Team
  • Portfolio
  • Impact
  • News
  • Contact
  • Français
Select Page

Lyon-based medtech MexBrain raises nearly €6 million from Arbevel, the French Tech Seed fund and Kreaxi for the clinical development of its medical device

To advance the clinical development of its medical device for the specific extraction of toxic free metals from the blood, MexBrain has announced the raising of 5.75 million euros. This round of financing brings together two institutional investors, Arbevel and...

Theranexus : 2020 full-year results and update on the progress of main programs

Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates modulating the interaction between neurons and glial cells, today announces its results for the year ending 31 December 2020...

Flexitron Group, the Spanish group dedicated to IoT markets acquires majority stake in Webdyn SA to extend its footprint in the energy transition market.

For José María Vilallonga Presas, chairman of the Flexitron Group, Webdyn is a nice fit in the Flexitron Group family: “Webdyn has a unique product portfolio: customers love their products and appreciate their functionalities and quality. Our team saw the market...

Amolyt Pharma Presents First Clinical Data for AZP-3601, its Parathyroid Hormone Analog for Hypoparathyroidism, at the Endocrine Society’s Virtual Annual Meeting (ENDO 2021)

Amolyt Pharma today presented positive data from the first cohorts of the single ascending dose portion of its Phase 1 clinical trial in healthy volunteers evaluating the company’s lead clinical candidate, AZP- 3601, for the treatment of hypoparathyroidism. The data...

Linkfluence is joining forces with Meltwater to accelerate is leadership in aI-enabled consumer insights

Consolidation continues in the social network monitoring market. Nearly 15 years after its creation, the French company Linkfluence, which helps brands identify weak signals on social networks, is going to continue its story under the American flag. Indeed, it has...

Theranexus presents an update on the progress of its main programs and announces its cash position as of 31 December 2020. Implemantation of a new equity line.

Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates modulating the interaction between neurons and glial cells (the “Company”), presents an update on its activities and...
« Older Entries
Next Entries »

Recent Posts

  • Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
  • Inalve raises 2m€ to accelerate the aquaculture transition toward a more sustainable industry
  • Amolyt Pharma Named ‘Biotech Company of the Year” at the LSX European Lifestars Awards
  • Greentech: MECAWARE secures €40m to become the leader in battery recycling and the production of strategic metals in France and Europe
  • Amolyt Pharma to Present Data on the Renal Effects of Eneboparatide, a PTHR1 Agonist in Phase 3 for the Treatment of Hypoparathyroidism, at the 39th Congress of the French Society of Endocrinology

Archives

  • March 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • June 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • October 2022
  • September 2022
  • August 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • May 2021
  • April 2021
  • March 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • July 2020
  • April 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • July 2019
  • March 2019
  • February 2019
  • December 2018
  • November 2018
  • December 2017
  • September 2017
  • April 2017

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

About us

Kreaxi is an investment management firm specialized in the equity financing of innovative, deeptech & lowtech startups with high growth potential. Kreaxi manages regional funds in France, focusing on Auvergne-Rhône-Alpes region as well as French and pan-european funds.

Lyon

101, Chemin Vert
69760 Limonest 
France

+33 4 72 52 39 39

Paris

13-15 rue Taitbout
75009 Paris
France

+33 1 73 02 89 69

  • X
© 2023 Kreaxi. Tous droits réservés. Mentions légales | Informations réglementaires.
Nous utilisons des cookies sur notre site web pour vous offrir l'expérience la plus adaptée en nous souvenant de vos préférences lors de vos prochaines visites. En cliquant sur “Tout accepter”, vous consentez à l'usage de l'ensemble des cookies. Cependant, vous pouvez visiter "Paramétrage" pour détailler votre consentement.
Reject all SettingsAccept all
Manage your consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
SAVE & ACCEPT